VENABLE LLP for BIG CITIES HEALTH COALITION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Tobacco TOB
FDA regulation of tobacco, nicotine, and synthetic nicotine; Banning menthol cigarettes and flavored cigars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA A HANEN | — |
Alcohol and Drug Abuse ALC
Substance use prevention, including naloxone, harm reduction, and Medication for Opioid Use Disorder; Elimination of X waiver; H.R. 1384/S. 445 - Mainstreaming Addiction Treatment Act; Delay Fentanyl scheduling as Schedule 1; S. 5167 TEST Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA A HANEN | — |
Health Issues HCR
Public health data authority; H.R. 9476 Protecting America from Seasonal and Pandemic Influenza.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA A HANEN | — |
Budget/Appropriations BUD
FY 2023 Labor-HHS-Education Appropriations bill; CDC funding for Advanced Molecular Detection, immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, Epi and Lab capacity, data modernization initiative, infectious disesases, opioid prevention, climate and health, public health workforce, public health capacity and infrastructure; Teen Pregnancy Prevention Program and Adolescent, School Health program and Title X; HRSA funding; FY2023 Supplemental Funding for Monkeypox and COVID.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA A HANEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.